Nanobiotix Aktie

2,88EUR -0,10EUR -3,42%
Nanobiotix für 0 Euro bei ZERO ordern (zzgl. Spreads)

WKN DE: A1J7EB / ISIN: FR0011341205

<
Kurse + Charts + Realtime
Kurs + Chart
Times + Sales
Börsenplätze
Historisch
>
<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>

Personal

2020 2021 2022 2023 2024
Personal am Ende des Jahres 90 100 102 102 108
Umsatz pro Mitarbeiter in Mio. EUR 0,00 0,00 0,00 0,29 -0,11

Bilanz (in Mio. EUR) - Aktiva

2020 2021 2022 2023 2024
Summe Umlaufvermögen 125 93 52 87 61
Summe Anlagevermögen 9 9 7 7 6
Summe Aktiva 134 102 60 94 67

Bilanz (in Mio. EUR) - Passiva

2020 2021 2022 2023 2024
Summe Fremdkapital 64 75 87 96 133
Summe Eigenkapital 70 27 -27 -2 -66
Summe Passiva 134 102 60 94 67

Adresse

60, rue de Wattignies, 75012 Paris
Telefon +33 (1) 40-26-04-70
Fax +33 (1) 40-26-04-44
Internet http://www.nanobiotix.com

Management

Alain Herrera
Member-Supervisory Board
Anne-Juliette Hermant
Chief People Officer
Anne-Marie Graffin
Deputy Chairman-Supervisory Board
Bart van Rhijn
Chief Financial & Business Officer
Craig West
Senior Vice President-Investor Relations
Enno Spillner
Member-Supervisory Board
Gary M. Phillips
Chairman-Supervisory Board
Laurent Lévy
Chairman-Executive Board & Chief Executive Officer
Louis Kayitalire
Chief Medical Officer
Margaret Galluzzi
Vice President & Head-Global Clinical Operations
Patrick Tricoli
Global Head-Business Development